Cite

HARVARD Citation

    Nielsen, L. et al. (2019). Clarithromycin added to bortezomib‐cyclophosphamide‐dexamethasone impairs health‐related quality of life in multiple myeloma patients. European journal of haematology. pp. 70-78. [Online]. 
  
Back to record